Annual Interest Expense
$55.20 M
-$17.80 M-24.38%
December 31, 2024
Summary
- As of February 20, 2025, REGN annual interest expense is $55.20 million, with the most recent change of -$17.80 million (-24.38%) on December 31, 2024.
- During the last 3 years, REGN annual interest expense has fallen by -$2.10 million (-3.66%).
- REGN annual interest expense is now -24.38% below its all-time high of $73.00 million, reached on December 31, 2023.
Performance
REGN Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$10.50 M
-$3.30 M-23.91%
December 31, 2024
Summary
- As of February 20, 2025, REGN quarterly interest expense is $10.50 million, with the most recent change of -$3.30 million (-23.91%) on December 31, 2024.
- Over the past year, REGN quarterly interest expense has dropped by -$7.80 million (-42.62%).
- REGN quarterly interest expense is now -60.08% below its all-time high of $26.30 million, reached on September 30, 2020.
Performance
REGN Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$55.20 M
-$7.80 M-12.38%
December 31, 2024
Summary
- As of February 20, 2025, REGN TTM interest expense is $55.20 million, with the most recent change of -$7.80 million (-12.38%) on December 31, 2024.
- Over the past year, REGN TTM interest expense has dropped by -$17.80 million (-24.38%).
- REGN TTM interest expense is now -24.38% below its all-time high of $73.00 million, reached on December 31, 2023.
Performance
REGN TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
REGN Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.4% | -42.6% | -24.4% |
| 3 y3 years | -3.7% | -42.6% | -24.4% |
| 5 y5 years | +82.8% | -42.6% | -24.4% |
REGN Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -24.4% | at low | -44.4% | at low | -24.4% | +0.4% |
| 5 y | 5-year | -24.4% | +82.8% | -60.1% | +72.1% | -24.4% | +93.0% |
| alltime | all time | -24.4% | +2262.0% | -60.1% | +182.3% | -24.4% | +759.4% |
Regeneron Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $55.20 M(-24.4%) | $10.50 M(-23.9%) | $55.20 M(-12.4%) |
| Sep 2024 | - | $13.80 M(-6.8%) | $63.00 M(-6.0%) |
| Jun 2024 | - | $14.80 M(-8.1%) | $67.00 M(-5.8%) |
| Mar 2024 | - | $16.10 M(-12.0%) | $71.10 M(-2.6%) |
| Dec 2023 | $73.00 M(+22.9%) | $18.30 M(+2.8%) | $73.00 M(+1.2%) |
| Sep 2023 | - | $17.80 M(-5.8%) | $72.10 M(+3.6%) |
| Jun 2023 | - | $18.90 M(+5.0%) | $69.60 M(+9.1%) |
| Mar 2023 | - | $18.00 M(+3.4%) | $63.80 M(+7.4%) |
| Dec 2022 | $59.40 M(+3.7%) | $17.40 M(+13.7%) | $59.40 M(+5.9%) |
| Sep 2022 | - | $15.30 M(+16.8%) | $56.10 M(+2.0%) |
| Jun 2022 | - | $13.10 M(-3.7%) | $55.00 M(-2.3%) |
| Mar 2022 | - | $13.60 M(-3.5%) | $56.30 M(-1.7%) |
| Dec 2021 | $57.30 M(+0.7%) | $14.10 M(-0.7%) | $57.30 M(-1.2%) |
| Sep 2021 | - | $14.20 M(-1.4%) | $58.00 M(-17.3%) |
| Jun 2021 | - | $14.40 M(-1.4%) | $70.10 M(+7.2%) |
| Mar 2021 | - | $14.60 M(-1.4%) | $65.40 M(+14.9%) |
| Dec 2020 | $56.90 M(+88.4%) | $14.80 M(-43.7%) | $56.90 M(+16.6%) |
| Sep 2020 | - | $26.30 M(+171.1%) | $48.80 M(+61.1%) |
| Jun 2020 | - | $9.70 M(+59.0%) | $30.30 M(+5.9%) |
| Mar 2020 | - | $6.10 M(-9.0%) | $28.60 M(-5.3%) |
| Dec 2019 | $30.20 M(+7.1%) | $6.70 M(-14.1%) | $30.20 M(-2.3%) |
| Sep 2019 | - | $7.80 M(-2.5%) | $30.90 M(+1.3%) |
| Jun 2019 | - | $8.00 M(+3.9%) | $30.50 M(+3.7%) |
| Mar 2019 | - | $7.70 M(+4.1%) | $29.40 M(+4.6%) |
| Dec 2018 | $28.20 M(+12.4%) | $7.40 M(0.0%) | $28.10 M(+5.2%) |
| Sep 2018 | - | $7.40 M(+7.2%) | $26.72 M(+4.8%) |
| Jun 2018 | - | $6.90 M(+7.8%) | $25.50 M(+6.2%) |
| Mar 2018 | - | $6.40 M(+6.4%) | $24.00 M(-4.4%) |
| Dec 2017 | $25.10 M(+248.6%) | $6.02 M(-2.7%) | $25.10 M(+14.6%) |
| Sep 2017 | - | $6.18 M(+14.5%) | $21.90 M(+35.1%) |
| Jun 2017 | - | $5.40 M(-28.0%) | $16.21 M(+34.4%) |
| Mar 2017 | - | $7.50 M(+166.7%) | $12.06 M(+67.5%) |
| Dec 2016 | $7.20 M | $2.81 M(+467.1%) | $7.20 M(-186.0%) |
| Sep 2016 | - | $496.00 K(-60.4%) | -$8.37 M(+10.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2016 | - | $1.25 M(-52.6%) | -$7.59 M(-178.5%) |
| Mar 2016 | - | $2.64 M(-120.7%) | $9.67 M(-32.1%) |
| Dec 2015 | $14.24 M(-61.9%) | -$12.76 M(-1102.2%) | $14.24 M(-57.3%) |
| Sep 2015 | - | $1.27 M(-93.1%) | $33.35 M(-19.3%) |
| Jun 2015 | - | $18.52 M(+156.8%) | $41.31 M(+25.3%) |
| Mar 2015 | - | $7.21 M(+13.5%) | $32.97 M(-11.8%) |
| Dec 2014 | $37.37 M(-19.5%) | $6.35 M(-31.2%) | $37.37 M(-12.4%) |
| Sep 2014 | - | $9.23 M(-9.3%) | $42.68 M(-5.5%) |
| Jun 2014 | - | $10.18 M(-12.4%) | $45.19 M(-2.6%) |
| Mar 2014 | - | $11.61 M(-0.4%) | $46.38 M(-0.1%) |
| Dec 2013 | $46.44 M(+2.5%) | $11.66 M(-0.6%) | $46.44 M(+0.4%) |
| Sep 2013 | - | $11.74 M(+3.3%) | $46.27 M(+0.7%) |
| Jun 2013 | - | $11.37 M(-2.7%) | $45.95 M(+0.3%) |
| Mar 2013 | - | $11.68 M(+1.6%) | $45.82 M(+1.1%) |
| Dec 2012 | $45.30 M(+112.9%) | $11.49 M(+0.7%) | $45.30 M(+4.7%) |
| Sep 2012 | - | $11.41 M(+1.6%) | $43.26 M(+20.5%) |
| Jun 2012 | - | $11.24 M(+0.7%) | $35.91 M(+25.0%) |
| Mar 2012 | - | $11.16 M(+18.0%) | $28.72 M(+35.0%) |
| Dec 2011 | $21.28 M(+133.4%) | $9.46 M(+132.8%) | $21.28 M(+49.0%) |
| Sep 2011 | - | $4.06 M(+0.3%) | $14.29 M(+14.7%) |
| Jun 2011 | - | $4.05 M(+8.8%) | $12.46 M(+15.9%) |
| Mar 2011 | - | $3.72 M(+51.3%) | $10.75 M(+17.9%) |
| Dec 2010 | $9.12 M(+290.2%) | $2.46 M(+10.0%) | $9.12 M(+8.3%) |
| Sep 2010 | - | $2.23 M(-4.6%) | $8.42 M(+24.4%) |
| Jun 2010 | - | $2.34 M(+12.4%) | $6.76 M(+53.0%) |
| Mar 2010 | - | $2.08 M(+18.7%) | $4.42 M(+89.2%) |
| Dec 2009 | $2.34 M(-69.9%) | $1.76 M(+202.2%) | $2.34 M(+302.2%) |
| Sep 2009 | - | $581.00 K(>+9900.0%) | $581.00 K(>+9900.0%) |
| Jun 2009 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2009 | - | $0.00(-100.0%) | $2.67 M(-53.0%) |
| Dec 2008 | $7.75 M(-35.6%) | - | - |
| Jun 2008 | - | $2.67 M(-11.2%) | $5.68 M(+88.8%) |
| Mar 2008 | - | $3.01 M | $3.01 M |
| Dec 2007 | $12.04 M | - | - |
FAQ
- What is Regeneron Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual interest expense year-on-year change?
- What is Regeneron Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly interest expense year-on-year change?
- What is Regeneron Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals TTM interest expense year-on-year change?
What is Regeneron Pharmaceuticals annual interest expense?
The current annual interest expense of REGN is $55.20 M
What is the all time high annual interest expense for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual interest expense is $73.00 M
What is Regeneron Pharmaceuticals annual interest expense year-on-year change?
Over the past year, REGN annual interest expense has changed by -$17.80 M (-24.38%)
What is Regeneron Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of REGN is $10.50 M
What is the all time high quarterly interest expense for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly interest expense is $26.30 M
What is Regeneron Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, REGN quarterly interest expense has changed by -$7.80 M (-42.62%)
What is Regeneron Pharmaceuticals TTM interest expense?
The current TTM interest expense of REGN is $55.20 M
What is the all time high TTM interest expense for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high TTM interest expense is $73.00 M
What is Regeneron Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, REGN TTM interest expense has changed by -$17.80 M (-24.38%)